Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zynerba Pharma CS (NQ: ZYNE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zynerba Pharma CS

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 838 companies hit new 52-week lows. 
Via Benzinga
Zynerba Pharmaceuticals Announces Poster Presentation at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
From Zynerba Pharmaceuticals, Inc.
Via GlobeNewswire
Psychedelic Drug Stocks Index Up Slightly This Week
There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD. 
Via Talk Markets
Zynerba Pharmaceuticals Announces Issuance of New U.S. Patent for Zygel™
From Zynerba Pharmaceuticals, Inc.
Via GlobeNewswire
September Cannabis Category Performances Ranged From -6.3% To -39.0%
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September... 
Via Talk Markets
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 402 companies made new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million. 
Via Benzinga
Major Psychedelic Stocks Continued To Decline In September
There are 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index. Most - but interestingly not all - were down for the week and/or the month. 
Via Talk Markets
Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
From Zynerba Pharmaceuticals, Inc.
Via GlobeNewswire
The 5 Cannabis Categories Fell Even Further Last Week
The 5 categories in the cannabis sector performed quite differently from each other again last week. The ones that lost least are the most peripheral to the growing and/or distribution of cannabis. 
Via Talk Markets
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
Cannabis Stock Gainers And Losers From September 21, 2022
GAINERS: Icanic Brands (OTC:ICNAF) shares closed up 18.62% at $0.07 
Via Benzinga
Cannabis Stock Gainers And Losers From September 20, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 8.89% at $0.49 
Via Benzinga
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently. 
Via Talk Markets
8 Largest Psychedelic Stocks Continued Their Decline Last Week
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks. 
Via Talk Markets
Cannabis Stock Gainers And Losers From September 15, 2022
GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 5.70% at $0.06 LOSERS: 
Via Benzinga
Cannabis Stock Gainers And Losers From September 12, 2022
GAINERS: Icanic Brands (OTC:ICNAF) shares closed up 9.79% at $0.08 
Via Benzinga
8 Largest Psychedelic Stocks Dropped Almost 12% This Week
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks. 
Via Talk Markets
Largest Psychedelic Stocks Up In August; Up 42% Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index are on average UP 18.5% in August. 
Via Talk Markets
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 2, 2022
GAINERS: Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 6.60% at $2.10 
Via Benzinga
Cannabis Stock Movers For August 29, 2022
GAINERS: Cann Gr (OTC:CNGGF) shares closed up 9.57% at $0.20 
Via Benzinga
How The 5 Cannabis Categories Performed Last Week
The cannabis sector consists of 5 distinctly different categories and they have each performed quite differently this past week, since the end of June and YTD. Only one is breaking even. 
Via Talk Markets
Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June
The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD. 
Via Talk Markets
Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
Bearish Monday For Marijuana Stocks
GAINERS: LOSERS: Canopy Gwth (NASDAQ:CGC) shares closed down 13.61% at $3.30 
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 19, 2022
GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 3.27% at $0.06 
Via Benzinga
A Comparison Of How The 5 Cannabis Categories Performed Last Week
The cannabis sector consists of 5 distinct categories and they have each performed quite differently this past week, since the end of June. 
Via Talk Markets
Bullish Sentiment Across The Cannabis Space - Check Full Movers For August 15, 2022
  
Via Benzinga
Major Psychedelic Stocks Down This Week; Still Up Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then. 
Via Talk Markets
Zynerba Pharmaceuticals R&D Expanses For Q2 Reach 5.4M, Here Are The Details
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), released financial results for the second quarter ended June 30, 2022. Q2 2022 Financial Highlights 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.